Your browser doesn't support javascript.
loading
Highlights of the 12th Japan Bioanalysis Forum Symposium.
Uchiyama, Hitoshi; Yamaguchi, Takeru; Arai, Koji; Arakawa, Tomoko; Igarashi, Harue; Ohtsu, Yoshiaki; Ochiai, Ryosuke; Kawai, Yosuke; Koseki, Nozomu; Komaba, Junji; Sano, Yoshihisa; Shimizu, Hisao; Takahashi, Makoto; Nagao, Akemi; Nakamura, Takahiro; Nishiguchi, Yumi; Hata, Katsutomo; Nakai, Keiko; Hara, Hisanori; Mabuchi, Masanari; Murao, Naoaki; Yoshinaga, Ryosuke.
Affiliation
  • Uchiyama H; Towa Pharmaceutical Co., Ltd, Kyoto, Kyoto, Japan.
  • Yamaguchi T; Sumika Chemical Analysis Service, Ltd, Osaka, Osaka, Japan.
  • Arai K; LSI Medience Corp., Chiyoda-ku, Tokyo, Japan.
  • Arakawa T; Pfizer R&D Japan G.K., Shibuya-ku, Tokyo, Japan.
  • Igarashi H; GlaxoSmithKline K.K., Minato-ku, Tokyo, Japan.
  • Ohtsu Y; Kyowa Kirin Co., Ltd, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan.
  • Ochiai R; ShimadzuTechno-Research, Kyoto, Kyoto, Japan.
  • Kawai Y; Otsuka Pharmaceutical Co., Ltd, Osaka, Osaka, Japan.
  • Koseki N; Kyorin Pharmaceutical Co., Ltd, Nogi-machi, Tochigi, Japan.
  • Komaba J; Ono Pharmaceutical Co., Ltd, Tsukuba, Ibaraki, Japan.
  • Sano Y; Sunplanet Co., Ltd, Tsukuba, Ibaraki, Japan.
  • Shimizu H; Takeda Pharmaceutical Co., Ltd, Fujisawa-shi, Kanagawa, Japan.
  • Takahashi M; Daiichi Sankyo Co., Ltd, Chuo-ku, Tokyo, Japan.
  • Nagao A; Japan Tobacco Inc., Takatsuki, Osaka, Japan.
  • Nakamura T; Shin Nippon Biomedical Laboratories, Ltd, Kagoshima, Kagoshima, Japan.
  • Nishiguchi Y; CMIC Pharma Science Co., Ltd, Nishiwaki, Hyogo, Japan.
  • Hata K; Shionogi & Co., Ltd, Toyonaka, Osaka, Japan.
  • Nakai K; LSIM Safety Institute Corp., Kamisu, Ibaraki, Japan.
  • Hara H; Novartis Pharma AG, Basel, Basel-Stadt, Switzerland.
  • Mabuchi M; Mitsubishi Tanabe Pharma Corp., Yokohama, Kanagawa, Japan.
  • Murao N; Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan.
  • Yoshinaga R; Toray Research Center, Inc., Kamakura, Kanagawa, Japan.
Bioanalysis ; 13(22): 1653-1657, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34657482
ABSTRACT
Approximately 300 people associated with pharmaceutical industries, contractors, academic institutions and regulatory authorities attended the 12th Japan Bioanalysis Forum Symposium. The webinar was conducted from 9 to 11 March 2021. The theme of the symposium was 'for the next generation', and the event provided 'an opportunity for young researchers in bioanalysis (including students)' and 'an opportunity to discuss new frontiers of bioanalysis'. The speakers focused on hot topics of bioanalysis, including biomarker analysis, patient centric sampling, virtual clinical trials, gene therapy, cancer genome medicine and therapeutic middle molecules. The symposium presented a platform for the discussion of the prospects and challenges facing bioanalysts working in the field of pharmacokinetics. This report presents the key issues discussed.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Assay Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Bioanalysis Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Assay Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Bioanalysis Year: 2021 Type: Article Affiliation country: Japan